Emergent Biosolutions Inc

Small-Cap Stocks Stocks Under $10 Biotech Stocks Healthcare Stocks

$8.21

+0.20 (+2.50%)

As of Mar 25, 10:04 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 5 83%

Hold 1 17%

Sell 0 0%

Price Target

Analyst Price Target +229.8% upside

Low Target $18.81

Average Target $27.08

High Target $37.55

Current Price $8.21

Current
$8.21

Target
$27.08

$18.81 $27.08 avg $37.55

Scenario Analysis

Bear Case

$18.81

129.1%

Low target

Base Case

$27.08

+229.8%

Avg target

Bull Case

$37.55

+357.4%

High target

Risk/Reward

2.8x

Favorable

Price in Context

52-Week High

$14.06

-41.6% from high

52-Week Low

$4.02

+104.2% from low

Target vs 52W High

$27.08

+92.6% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	39	69%	$257.58	+24.3%
AMGN Amgen Inc	Hold	42	50%	$190.87	-46.1%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+162.3%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	-3.7%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-89.8%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	78%	$102.31	-68.9%
INSM Insmed Inc	Strong Buy	26	92%	$143.40	-3.3%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-27.6%